The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...
Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...
WEST PALM BEACH, Fla. — Discontinuing disease-modifying therapies (DMTs) for multiple sclerosis (MS) after prolonged disease stability poses minimal risk for patients aged > 60 years, highlighting the ...
A woman living with multiple sclerosis (MS) has shared how she has found joy through pottery. Sarah Reeve, from Tunbridge ...
—Clinicians may be underestimating the cognitive burden on patients with MS, underscoring the need for more comprehensive cognitive assessments and assessing patient-reported outcomes. A growing body ...
“This study found that having bladder problems was significantly associated with lower well-being in [people with] MS, particularly when considering OAB. Bowel problems, self-management of bladder ...
While it is well known that heat can lead to worsening of the symptoms of multiple sclerosis—a chronic autoimmune disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback